Jane Street
LFCR icon

Jane Street’s Lifecore Biomedical LFCR Stock Holding History

Jane Street’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,200
Closed -$83.4K – 12367
2025
Q4 		$83.4K Buy
+10,200
New +$75.5K ﹤0.01% 10277
2023
Q4 		– Sell
-22,500
Closed -$170K – 9535
2023
Q3 		$170K Sell
22,500
-7,700
-25% -$70.4K ﹤0.01% 7725
2023
Q2 		$292K Buy
+30,200
New +$184K ﹤0.01% 7160

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jane Street's LFCR Position: Q2 2026 in Review

Jane Street opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 29,076 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #10336 among its holdings. This is a return to the name: Jane Street previously reported a position in LFCR as recently as Q4 2025.

Jane Street first reported a position in LFCR in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.57M in Q1 2024. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Jane Street held 29,076 shares of Lifecore Biomedical worth $153K as of Q2 2026.
  • Lifecore Biomedical was a new Jane Street position in Q2 2026.
  • Lifecore Biomedical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10336 holding.
  • Jane Street first reported a position in Lifecore Biomedical in Q2 2021 and has held it in 10 quarters since.
  • Jane Street's Lifecore Biomedical position peaked at $1.57M in Q1 2024.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.